Abstract:Objectives The primary aim was the validation of benign descriptors (BDs), followed by Assessment of Different NEoplasia's of the adneXa (ADNEX) (when BDs cannot be applied), in a two‐step strategy to classify adnexal masses in pregnancy. The secondary aim was to describe the natural history of adnexal masses in pregnancy. Methods Retrospective analysis of prospectively collected data of women with an adnexal mass on ultrasonography identified during pregnancy between 2017 and 2022. The study was conducted at Queen Charlotte's and Chelsea Hospital, UK. Relevant clinical and ultrasound data were extracted from the medical records and ultrasound software astraia. Adnexal masses were classified and managed according to expert subjective assessment (SA). Ultrasound features were recorded prospectively at the time of ultrasound examination. Borderline ovarian tumours (BOT) were classified as malignant. Benign Descriptors (BDs) were applied to classify adnexal masses, in cases where BDs were not applicable, the ADNEX model (using a risk of malignancy of >10%) was used, in a two‐step strategy. The two‐step strategy was applied retrospectively. The reference standard used was histology (where available) or expert SA at the postnatal ultrasound scan. Results 291 women with a median age of 33 (IQR 29‐36) years presented with an adnexal mass in pregnancy, at a median gestation of 12 (IQR 8‐17) weeks. 267 (267/291, 91.8%) women were followed up to the postnatal period, as 24 women (24/291, 8.2%) were lost to follow up. Based on the reference standard, 4.1% of adnexal masses (11/267) were classified as malignant (all BOTs) and 95.9% (256/267) as benign (41 on histology and 215 based on expert SA at postnatal ultrasound). BDs could be applied to 68.9% of adnexal masses (184/267); of these only one mass (BOT) was misclassified as benign (1/184, 0.5%). ADNEX was used to classify the residual masses (83/267) and misclassified three BOTs as benign (3/10, 30.0%) and 25 benign masses (based on reference standard) as malignant (25/73, 34.2%), 13 (13/25, 52.0%) of these were classified as decidualised endometriomas on expert SA, with confirmed resolution of decidualisation in the postnatal period. The two‐step strategy had a specificity of 90.2%, sensitivity of 63.6%, negative predictive value of 98.3% and positive predictive value of 21.9%. 56 (56/267, 21.0%) women had surgical intervention, four as an emergency during pregnancy (4/267, 1.5%,) and four (4/267, 1.5%) electively during caesarean section. 48 (48/267, 18.0%) women had surgical intervention in the post‐natal period, 11 (11/267, 4.1%) in the first 12 weeks postnatal and 37 >12 weeks (37/267, 13.9%) postnatal. 64 (64/267, 24.0%) adnexal masses resolved spontaneously during follow up. Cyst‐related complications occurred in four women (4/267, 1.5%) during pregnancy (ovarian torsion n=2, cyst rupture n=2) and six (6/267, 2.2%) in the postnatal period (all ovarian torsion). 196 (196/267, 73.4%) had a persistent adnexal mass, including one of the women who had an ovarian torsion and underwent de‐torsion and had a persistent adnexal mass at postnatal ultrasound. Presumed decidualisation occurred in 31.1% (19/61) of endometriomas and had resolved in 89.5% (17/19) by the first postnatal ultrasound scan. Conclusion We found Benign Descriptors apply to most masses in pregnancy, however the small number of malignant tumours in the cohort (4.1%) restricted the evaluation of the ADNEX model, so expert subjective assessment should be used to classify adnexal masses in pregnancy, when BDs do not apply. A larger multicentre prospective study is required to evaluate the use of the ADNEX model to classify adnexal masses in pregnancy. Our data suggests that most adnexal masses can be managed expectantly during pregnancy given a large proportion of masses spontaneously resolved and the low risk of complications. This article is protected by copyright. All rights reserved.

EP23.40: Experience with the modified benign descriptor four in the diagnosis of unclassified benign adnexal masses

EP23.16: Diagnostic accuracy of modified benign descriptor three in the diagnosis of simple cysts and cystadenomas

EP23.21: Diagnostic accuracy of modified benign descriptor two in the diagnosis of teratomas

OP06.05: Diagnostic accuracy of modified benign descriptor one in the diagnosis of endometriomas

EP23.27: Female adnexal tumour of probable Wolffian origin: ultrasonographic imaging characteristics

EP23.19: Diagnostic accuracy of ultrasound scoring systems in differentiating benign versus malignant adnexal masses

Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification

OP06.04: Discrimination of benign and malignant adnexal masses in daily clinical routine: external validation of ADNEX and RMI in Denmark – preliminary results

Three-dimensional sonographic morphologic assessment in complex adnexal masses: preliminary experience

OP06.03: Preoperative sonographic evaluation of adnexal masses using the new Ovarian‐Adnexal Reporting and Data System

Evaluating use of IOTA two‐step strategy to classify adnexal masses identified in pregnancy: pilot study

EP23.61: Ultrasound‐based DML models performance versus expert subjective assessment for discriminating adnexal masses: a head‐to‐head meta‐analysis

EP24.17: Experience in the diagnosis of endometriosis with ultrasound mapping versus magnetic resonance imaging

EP23.45: ADNEX versus expert opinion: a meta‐analysis comparing the performance of methodical assessment to subjective assessment for evaluating adnexal masses

EP23.65: Serum Ca‐125 levels in postmenopausal women with adnexal masses and risk stratification based on Ovarian‐Adnexal Reporting and Data System

EP23.37: Ultrasonography experience may not be a reliable indicator for improved accuracy in assessing malignancy in adnexal tumours using the ADNEX model

EP23.63: Serous multilocular cystadenoma in a 12‐year‐old patient: a case report

EP23.23: Diagnosis of adnexal lesions using ultrasound‐based artificial intelligence

EP24.12: Prevalence of adenomyosis and endometriosis on ultrasound among symptomatic patients stratified by referring physician

EP24.04: Retroperitoneal benign and malignant pelvic masses: presurgical ultrasound diagnosis, histologic and endoscopic correlations

EP23.59: IOTA simple rules to diagnose the benign and malignant value of ≤ 6cm masses in the adnexal area